CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma

Publication Name : Thoracic Cancer

DOI : 10.1111/1759-7714.14853

Date : April 2023


Type
Journal
ISSN
17597706
Volume
14
Page
1089-1097